ENvue Medical (FEED) EBT Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -2.47% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 37.81% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 4.82% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 32.11% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 61.06% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.57% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 14.40% |
| 10 | ENvue Medical | 2.97 Mn | 709,615.89 | -55,000.00 | -51.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.25% |
| Dec 31, 2025 | -83.73% |
| Sep 30, 2025 | 37.15% |
| Jun 30, 2025 | -44.86% |
| Mar 31, 2025 | -30.15% |
| Dec 31, 2024 | 41.92% |
| Sep 30, 2024 | 46.79% |
| Jun 30, 2024 | -45.95% |
| Mar 31, 2024 | 50.86% |
| Dec 31, 2023 | 6.59% |
| Sep 30, 2023 | 8.40% |
| Jun 30, 2023 | 10.36% |
| Mar 31, 2023 | -6.29% |
| Dec 31, 2022 | 1,553.72% |
| Sep 30, 2022 | -4.96% |
| Jun 30, 2022 | -5.31% |
| Mar 31, 2022 | 25.00% |
| Dec 31, 2021 | 29.46% |
| Sep 30, 2021 | -70.48% |
| Jun 30, 2021 | 35.35% |
| Mar 31, 2021 | -84.70% |
| Dec 31, 2020 | 15.59% |
| Sep 30, 2020 | 15.98% |
| Jun 30, 2020 | -20.68% |
| Mar 31, 2020 | -1.74% |
| Dec 31, 2019 | -6.06% |
| Sep 30, 2019 | -10.84% |
| Jun 30, 2019 | -22.43% |
| Mar 31, 2019 | -76.39% |
| Dec 31, 2018 | -109.82% |
| Sep 30, 2018 | -9.30% |
| Jun 30, 2018 | -23.80% |
| Mar 31, 2018 | -7.47% |
| Dec 31, 2017 | -28.01% |
| Sep 30, 2017 | -27.56% |
| Jun 30, 2017 | -13.84% |
| Mar 31, 2017 | -21.32% |